• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高流量鼻导管给氧呼吸衰竭患者的液体平衡预测其插管需求。

Fluid Balance Predicts Need for Intubation in Subjects With Respiratory Failure Initiated on High-Flow Nasal Cannula.

机构信息

Division of Pulmonary, Critical Care and Sleep Medicine, Medstar Georgetown University Hospital, Washington DC.

出版信息

Respir Care. 2021 Apr;66(4):566-572. doi: 10.4187/respcare.07688. Epub 2020 Oct 19.

DOI:10.4187/respcare.07688
PMID:33077679
Abstract

BACKGROUND

High-flow nasal cannula (HFNC) has gained widespread use for acute hypoxemic respiratory failure on the basis of recent publications that demonstrated fewer intubations and perhaps lower mortality in certain situations. However, a subset of patients initiated on HFNC for respiratory failure ultimately do require intubation. Our goal was to identify patient-level features predictive of this outcome.

METHODS

This was a retrospective cohort study of subjects with hypoxemic respiratory failure treated with HFNC. Individuals were described as having succeeded (if weaned from HFNC) or failed (if they required intubation). A variety of easily measurable variables were evaluated for their ability to predict intubation risk, analyzed via a multivariate logistic regression model.

RESULTS

Of a total of 74 subjects, 42 succeeded and 32 failed. The mean ± SD net fluid balance in the first 24 h after HFNC initiation was significantly lower in the success group versus the failure group (-33 ± 80 mL/h vs 72 ± 117 mL/h; < .01). An adjusted model found only fluid balance and the previously described respiratory rate (breathing frequency [f]) to oxygenation (ROX) index ([[Formula: see text]/[Formula: see text]]/f) at 12 h as significant predictors of successful weaning (negative fluid balance adjusted odds ratio 0.77 [95% CI 0.62-0.96] for -10 mL/h increments [ = .02]; ROX adjusted OR 1.72 [1.15-2.57], < .01).

CONCLUSIONS

A negative fluid balance while on HFNC discriminated well between those who required intubation versus those who were successfully weaned.

摘要

背景

高流量鼻导管(HFNC)在最近的一些出版物中得到了广泛应用,这些出版物表明在某些情况下,HFNC 可减少插管的需求,并且可能降低死亡率,因此用于治疗急性低氧性呼吸衰竭。然而,有一部分接受 HFNC 治疗的呼吸衰竭患者最终需要插管。我们的目标是确定可预测这一结果的患者个体特征。

方法

这是一项回顾性队列研究,纳入了接受 HFNC 治疗的低氧性呼吸衰竭患者。根据患者是否成功(从 HFNC 成功撤机)或失败(需要插管)进行分组。通过多变量逻辑回归模型,评估了多种易于测量的变量对插管风险的预测能力。

结果

在总共 74 名患者中,有 42 名成功,32 名失败。HFNC 治疗开始后 24 小时内的净液体平衡在成功组与失败组之间差异有统计学意义(-33 ± 80 毫升/小时对 72 ± 117 毫升/小时; <.01)。调整后的模型仅发现液体平衡和之前描述的呼吸频率(f)与氧合指数(ROX)在 12 小时时是成功撤机的显著预测因素(负液体平衡调整后比值比 0.77[95%CI 0.62-0.96],每减少 10 毫升/小时[ =.02];ROX 调整后比值比 1.72[1.15-2.57], <.01)。

结论

HFNC 期间的负液体平衡可很好地区分需要插管和成功撤机的患者。

相似文献

1
Fluid Balance Predicts Need for Intubation in Subjects With Respiratory Failure Initiated on High-Flow Nasal Cannula.高流量鼻导管给氧呼吸衰竭患者的液体平衡预测其插管需求。
Respir Care. 2021 Apr;66(4):566-572. doi: 10.4187/respcare.07688. Epub 2020 Oct 19.
2
High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success.高流量鼻导管治疗 COVID-19:使用 ROX 指数预测成功。
Respir Care. 2021 Jun;66(6):909-919. doi: 10.4187/respcare.08631. Epub 2020 Dec 16.
3
High-Flow Nasal Cannula Versus Bag-Valve-Mask for Preoxygenation Before Intubation in Subjects With Hypoxemic Respiratory Failure.在低氧血症性呼吸衰竭患者中,高流量鼻导管与袋阀面罩用于插管前预给氧的比较。
Respir Care. 2016 Sep;61(9):1160-7. doi: 10.4187/respcare.04413. Epub 2016 Jun 7.
4
ROX index and SpO2/FiO2 ratio for predicting high-flow nasal cannula failure in hypoxemic COVID-19 patients: A multicenter retrospective study.ROX 指数和 SpO2/FiO2 比值预测低氧血症 COVID-19 患者高流量鼻导管治疗失败的多中心回顾性研究。
PLoS One. 2022 May 12;17(5):e0268431. doi: 10.1371/journal.pone.0268431. eCollection 2022.
5
Predicting the successful application of high-flow nasal oxygen cannula in patients with COVID-19 respiratory failure: a retrospective analysis.预测高流量鼻氧管在 COVID-19 呼吸衰竭患者中的成功应用:一项回顾性分析。
Expert Rev Respir Med. 2023 Apr;17(4):319-328. doi: 10.1080/17476348.2023.2199157. Epub 2023 Apr 5.
6
Factors associated with intubation in patients with acute hypoxaemic respiratory failure treated with high-flow nasal cannula oxygen therapy: A prospective, observational study.高流量鼻导管氧疗治疗急性低氧性呼吸衰竭患者插管的相关因素:一项前瞻性观察研究。
Aust Crit Care. 2024 May;37(3):455-460. doi: 10.1016/j.aucc.2023.03.005. Epub 2023 May 23.
7
Modified Respiratory Rate Oxygenation Index: An Early Warning Index for the Need of Intubation in COVID-19 Patients with High-Flow Nasal Cannula Therapy.改良呼吸频率氧合指数:高流量鼻导管治疗的 COVID-19 患者需要插管的早期预警指标。
J Emerg Med. 2023 Aug;65(2):e93-e100. doi: 10.1016/j.jemermed.2023.04.026. Epub 2023 May 26.
8
The use of respiratory rate-oxygenation index to predict failure of high-flow nasal cannula in patients with coronavirus disease 2019-associated acute respiratory distress syndrome: A retrospective study.应用呼吸频率-氧合指数预测 2019 冠状病毒病相关急性呼吸窘迫综合征患者使用高流量鼻导管治疗失败:一项回顾性研究。
PLoS One. 2023 Jun 21;18(6):e0287432. doi: 10.1371/journal.pone.0287432. eCollection 2023.
9
Factors Associated With Failure of High-Flow Nasal Cannula.与高流量鼻导管失败相关的因素。
Respir Care. 2020 Sep;65(9):1276-1284. doi: 10.4187/respcare.07403. Epub 2020 Mar 24.
10
Respiratory rate‑oxygenation (ROX) index for predicting high-flow nasal cannula failure in patients with and without COVID-19.用于预测 COVID-19 患者和非 COVID-19 患者高流量鼻导管失败的呼吸频率-氧合(ROX)指数。
Am J Emerg Med. 2024 Jan;75:53-58. doi: 10.1016/j.ajem.2023.09.036. Epub 2023 Oct 14.

引用本文的文献

1
Noninvasive respiratory support in the emergency department: Controversies and state-of-the-art recommendations.急诊科的无创呼吸支持:争议与最新建议。
J Am Coll Emerg Physicians Open. 2024 Mar 7;5(2):e13118. doi: 10.1002/emp2.13118. eCollection 2024 Apr.
2
Predicting Failure of Noninvasive Respiratory Support Using Deep Recurrent Learning.使用深度递归学习预测无创呼吸支持失败。
Respir Care. 2023 Apr;68(4):488-496. doi: 10.4187/respcare.10382. Epub 2022 Dec 21.